William J. Lu

Internal Medicine
1823 Union St
San Francisco, CA 94123

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response.

ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response.

Journal: Oncotarget
Published: October 06, 2025

Non-viral precision T cell receptor replacement for personalized cell therapy.

Non-viral precision T cell receptor replacement for personalized cell therapy.

Journal: Nature
Published: June 16, 2022

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.

Journal: Nature
Published: May 29, 2020
Showing 1-3 of 3

Last Updated: 09/26/2026